Tp. Obrien et al., EFFICACY OF OFLOXACIN VS CEFAZOLIN AND TOBRAMYCIN IN THE THERAPY FOR BACTERIAL KERATITIS - REPORT FROM THE BACTERIAL-KERATITIS-STUDY-RESEARCH-GROUP, Archives of ophthalmology, 113(10), 1995, pp. 1257-1265
Purpose: To compare ofloxacin solution with a combination of fortified
antibiotic cefazolin sodium and tobramycin sulfate solutions in the t
reatment of bacterial keratitis. Methods: Patients under care at any o
ne of 28 participating clinical centers who had an eye with suspected
bacterial keratitis were randomly allocated in a double-masked manner
to treatment with 0.3% ofloxacin solution or a combination of the fort
ified antibiotics (1.5% tobramycin and 10.0% cefazolin solutions). Mai
n Outcome Measures: Time to healing defined as complete re-epithelizat
ion, accompanied by a nonprogressive stromal infiltrate for two consec
utive visits. Secondary outcome measures included patient symptoms and
signs of infection and adverse reactions to study medications. Only p
atients with a positive bacterial corneal culture were included in mos
t analyses. Results: A positive bacterial corneal culture was obtained
in 140 (56%) of the 248 enrolled patients. The time to healing was si
milar among the 73 patients receiving ofloxacin and the 67 patients re
ceiving fortified antibiotics (P=.70). By 7 days after study entry, th
e keratitis in 37% of the ofloxacin group and 38% of the fortified ant
ibiotics group had healed. By 28 days, keratitis in 89% of the ofloxac
in group and 86% of the fortified antibiotics group had healed. Two pa
tients receiving ofloxacin and one receiving fortified antibiotics dis
continued study medication because of lack of efficacy. Patients recei
ving ofloxacin reported substantially less burning and stinging on ins
tillation than the patients receiving fortified antibiotics (P<.001).
Five of six patients among the 140 with positive bacterial cultures wh
o had study medications discontinued because of ocular side effects we
re in the fortified antibiotics group; an additional three patients, a
ll in the fortified antibiotics group, among the remaining 108 receivi
ng study medications had ocular side effects. Conclusions: The efficac
y of ofloxacin solution in treating bacterial keratitis is equivalent
to that of the fortified cefazolin and tobramycin solutions. The reduc
ed frequency of ocular toxic effects and the relative ease of preparat
ion of ofloxacin are additional considerations.